rs41274865

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000155.4(GALT):​c.378-27G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0599 in 1,614,114 control chromosomes in the GnomAD database, including 3,193 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.047 ( 261 hom., cov: 32)
Exomes 𝑓: 0.061 ( 2932 hom. )

Consequence

GALT
NM_000155.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 1.55

Publications

18 publications found
Variant links:
Genes affected
GALT (HGNC:4135): (galactose-1-phosphate uridylyltransferase) Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
GALT Gene-Disease associations (from GenCC):
  • classic galactosemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • galactosemia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 2 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-34647805-G-C is Benign according to our data. Variant chr9-34647805-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 25166.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0626 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALTNM_000155.4 linkc.378-27G>C intron_variant Intron 4 of 10 ENST00000378842.8 NP_000146.2 P07902-1B2RAT6A0A0S2Z3Y7
GALTNM_001258332.2 linkc.51-27G>C intron_variant Intron 2 of 8 NP_001245261.1 P07902-2B2RAT6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALTENST00000378842.8 linkc.378-27G>C intron_variant Intron 4 of 10 1 NM_000155.4 ENSP00000368119.4 P07902-1
ENSG00000258728ENST00000556278.1 linkc.253-310G>C intron_variant Intron 2 of 7 5 ENSP00000451792.1 G3V4G9

Frequencies

GnomAD3 genomes
AF:
0.0469
AC:
7137
AN:
152136
Hom.:
260
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0123
Gnomad AMI
AF:
0.163
Gnomad AMR
AF:
0.0488
Gnomad ASJ
AF:
0.0481
Gnomad EAS
AF:
0.00946
Gnomad SAS
AF:
0.0687
Gnomad FIN
AF:
0.0672
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0642
Gnomad OTH
AF:
0.0441
GnomAD2 exomes
AF:
0.0543
AC:
13652
AN:
251492
AF XY:
0.0565
show subpopulations
Gnomad AFR exome
AF:
0.0125
Gnomad AMR exome
AF:
0.0473
Gnomad ASJ exome
AF:
0.0512
Gnomad EAS exome
AF:
0.00870
Gnomad FIN exome
AF:
0.0687
Gnomad NFE exome
AF:
0.0613
Gnomad OTH exome
AF:
0.0599
GnomAD4 exome
AF:
0.0613
AC:
89600
AN:
1461860
Hom.:
2932
Cov.:
33
AF XY:
0.0618
AC XY:
44978
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.0103
AC:
345
AN:
33478
American (AMR)
AF:
0.0481
AC:
2149
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0512
AC:
1338
AN:
26136
East Asian (EAS)
AF:
0.00645
AC:
256
AN:
39700
South Asian (SAS)
AF:
0.0755
AC:
6512
AN:
86258
European-Finnish (FIN)
AF:
0.0678
AC:
3624
AN:
53420
Middle Eastern (MID)
AF:
0.0465
AC:
268
AN:
5768
European-Non Finnish (NFE)
AF:
0.0644
AC:
71594
AN:
1111982
Other (OTH)
AF:
0.0582
AC:
3514
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
5689
11378
17066
22755
28444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2650
5300
7950
10600
13250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0469
AC:
7139
AN:
152254
Hom.:
261
Cov.:
32
AF XY:
0.0467
AC XY:
3475
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0123
AC:
510
AN:
41554
American (AMR)
AF:
0.0488
AC:
747
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0481
AC:
167
AN:
3472
East Asian (EAS)
AF:
0.00928
AC:
48
AN:
5170
South Asian (SAS)
AF:
0.0685
AC:
330
AN:
4816
European-Finnish (FIN)
AF:
0.0672
AC:
713
AN:
10610
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0642
AC:
4369
AN:
68020
Other (OTH)
AF:
0.0445
AC:
94
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
352
704
1057
1409
1761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0549
Hom.:
51
Bravo
AF:
0.0421
Asia WGS
AF:
0.0340
AC:
118
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase Benign:4Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 06, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Galactosemia Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.5
DANN
Benign
0.43
PhyloP100
1.6
BranchPoint Hunter
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41274865; hg19: chr9-34647802; COSMIC: COSV66592691; COSMIC: COSV66592691; API